Blood protein predictors of brain amyloid for enrichment in clinical trials?
Nicholas J Ashton,
Steven J Kiddle,
John Graf,
Malcolm Ward,
Alison L Baird,
Abdul Hye,
Sarah Westwood,
Karyuan Vivian Wong,
Richard J Dobson,
Gil D Rabinovici,
Bruce L Miller,
Howard J Rosen,
Andrew Torres,
Zhanpan Zhang,
Lennart Thurfjell,
Antonia Covin,
Cristina Tan Hehir,
David Baker,
Chantal Bazenet,
Simon Lovestone,
AIBL Research Group
Jun 08, 2018
BACKGROUND: Measures of neocortical amyloid burden (NAB) identify individuals who are at substantially greater risk of developing Alzheimer's disease (AD). Blood-based biomarkers predicting NAB would have great utility for the...